Pitney Bowes Inc Stock News

UST Platform''s Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets South Easton, MA, December 22, 2021 Pressure BioSciences, Inc. (OTCQB: PBIO ) (PBI or the Company), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and innovative services to the worldwide biotechnology, biotherapeutics, cosmetics, nutraceuticals, agrochemical, and food & beverage industries, today announced that hemp-derived cannabidiol (CBD) processed with its patented Ultra Shear Technology (UST) platform produced high-quality water-soluble nanoemulsions of CBD oil in water that have now demonstrated rock-solid visual and analytical stability 18 months after production and baseline testing. CBD is a widely popular therapeutic for relief of anxiety, depression, and PTSD, as well as chronic inflammatory and neuropathic pain . It is FDA-approved for use in the control of epileptic seizures in Lennox-Gastaut syndrome and Dravet syndrome .

(PR-inside.com) UST Platform''s Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets SOUTH EASTON, MA / ACCESSWIRE / December 22, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and innovative services to the worldwide biotechnology, biotherapeutics, cosmetics, nutraceuticals, agrochemical, and food & beverage industries, today announced that hemp-derived cannabidiol ("CBD") processed with its patented Ultra Shear Technology ("UST") platform produced high-quality water-soluble nanoemulsions of CBD oil in water that have now demonstrated rock-solid visual and analytical stability 18 months after production and baseline testing. CBD ..

The pandemic has caused tenant wish lists to change.

NEW YORK , Dec. 15, 2021 /PRNewswire/ -- MFA Financial, Inc. (NYSE: MFA) announced today that its Board of Directors has elected Sheila A. Stamps to its Board effective immediately. "We couldn''t be more pleased to welcome Sheila to the MFA Board," said Laurie Goodman , MFA''s Board Chair. "Her extensive involvement across a broad mix of industries, as well as her experience in strategy, business development, risk management and regulatory matters, will provide significant benefits to MFA''s management team, Board and stockholders. We look forward to having Sheila''s expertise and perspective as we diversify and further strengthen our Board with her addition." Ms. Stamps currently serves on the Board of Directors of Atlas Air Worldwide Holdings, Inc., a leading global provider of outsourced aircraft and aviation operating services, where she also serves as Chair of the Audit and Finance Committee, and Pitney Bowes Inc., a global shipping and mailing company that provides services to businesses and governments, where she also serves on the Audit and Executive Compensation Committees.

Image Provided By Unsplash The following post was written and/or published as a collaboration between Benzingas in-house sponsored content team and a financial partner of Benzinga. Pressure BioSciences, Inc. (OTCQB: PBIO ) is the biotech pioneer behind a range of pressure-based technology platforms that have been helping researchers and manufacturers across pharmaceuticals, nutraceuticals, cosmetics, agrochem, and many other industries develop more effective, reliable, and stable products for consumers. Hundreds of research and manufacturing labs worldwide are already using the technology, which relies on precision-controlled pressure to manipulate substances ranging from oils to proteins and other biomolecules. While many high value medical sciences companies like Pfizer (NYSE: PFE ), Merck (NYSE: MRK ), and AstraZeneca (NASDAQ: AZN ) are always searching for cutting-edge mechanisms like this, Pressure BioSciences, Inc. (PBI) jumped the innovation gap and has made a significant contribution to the sector.

STAMFORD, Conn.--(BUSINESS WIRE)--Pitney Bowes Inc. (NYSE: PBI), a global shipping and mailing company that provides technology, logistics, and financial services, today announced it has been named to the Drucker Institute’s Management Top 250. The Management Top 250 measures corporate effectiveness by examining performance in five areas: customer satisfaction, employee engagement and development, innovation, social responsibility and financial strength. The Company also landed in the Top 10 in

We take a look at the action in preferreds and baby bonds through the fourth week of November and highlight some of the key themes we are watching. Preferreds are having a tough November - the worst m

Picture credit: National Cancer Institute The following post was written and/or published as a collaboration between Benzingas in-house sponsored content team and a financial partner of Benzinga. The global genomics industry could be worth up to $27 billion by 2025, the global proteomics sector even more at $72 billion . Massachusetts-based Pressure BioSciences Inc. (PBI) (OTCQB: PBIO ) is aiming to take advantage of such growth by developing and commercializing patented technologies to aid drug manufacturers in the design, development, characterization and quality control of such therapeutics. While genomics is the study of human genes and how they interact with each other as well as with the environment, proteomics studies the entire protein system in any one individual organism. Such research can give vital clues as to how to detect, treat, and cure disease. PBIs approach and contribution to this field is the use of two of its patented technology platforms: Pressure Cycling Technology (PCT) and the BaroFold Technology (BaroFold).

Ever wonder what customers actually think of the unboxing process, or where shoppers get stuck during checkout on a site?

First Citizens Bank & Trust Co. purchased a new stake in shares of Pitney Bowes Inc. (NYSE:PBI) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 33,470 shares of the technology companys stock, valued at approximately $242,000. Other hedge funds have also recently []

STAMFORD, Conn.--(BUSINESS WIRE)--Pitney Bowes, a global shipping and mailing company that provides technology, logistics, and financial services, today released new findings from its weekly BOXpoll® consumer survey days before Black Friday / Cyber Monday (BFCM) weekend. “Compared to last year, U.S. consumers are shopping earlier and plan to take greater advantage of Black Friday / Cyber Monday deals, ship more gifts to more loved ones, and increase spending on gift cards,” said Vijay Ramachand

Many investors are wondering what to do with this new Kyndryl stock. Is it a better buy than the parent company, IBM?

Credit Suisse AG raised its stake in Pitney Bowes Inc. (NYSE:PBI) by 4.5% in the second quarter, HoldingsChannel reports. The fund owned 159,331 shares of the technology companys stock after purchasing an additional 6,923 shares during the period. Credit Suisse AGs holdings in Pitney Bowes were worth $1,410,000 as of its most recent filing with []

Thrivent Financial for Lutherans cut its position in shares of Pitney Bowes Inc. (NYSE:PBI) by 6.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 548,090 shares of the technology companys stock after selling 39,821 shares during the period. Thrivent Financial for []